摘要
目的:观察拉米夫定联合胸腺肽治疗慢性乙型肝炎的效果.方法:将50例慢性乙型肝炎病人,随机分为治疗组25例,给予拉米夫定100mg,qd疗程12月;胸腺肽160mg,每周2次,疗程6月.对照组25例,给予拉米夫定100mg,qd疗程12月.结果:治疗组总有效率88.0%;对照组总有效率56.0%,两组总有效率相比有显著差异性(x^2=6.39,P<0.05).结论:拉米夫定联合胸腺肽治疗慢性乙型肝炎疗效肯定,可作为一种有效的治疗方法.
Objective： To invesitigate the clinical effects of Lamivudine and Thymic Peptide treating Chronic Hepatitis B Patients.Methods： 50 patients were divided into two groups randomly . Treatment group 25 patients were treated with Lamivudine and Thymic Peptide; Control group 25 patients were treated with Lamivudine only.Results： The effective rate was 88.0% in treatment group and 56.0% in control group. The difference was very significant between two group （X^2 = 6.39, P 〈 0.05）. Conclusion Lamivudine and Thymic Peptide have significandly effects on Chronic Hepatitis B patients.
出处
《中国医药导刊》
2005年第4期286-287,共2页
Chinese Journal of Medicinal Guide
